INTRODUCTION
Regulated cell death including apoptosis and necroptosis plays essential roles in the development, homeostasis, and pathological processes of mammals. Apoptosis can be triggered through the death receptors (DRs), including tumor necrosis factor receptor-1 (TNFR1) and FAS (Nagata, 1997) . Activated by their ligands, DRs recruit the adaptor protein Fas-associated death domain (FADD), which binds and activates caspase-8 to initiate apoptosis (Boldin et al., 1996; Muzio et al., 1996; Zhang and Winoto, 1996) . In the absence of active caspase-8, receptor-interacting protein kinase 1 (RIPK1) and RIPK3 interact with each other, forming a microfilament-like complex that is known as necrosome Orozco et al., 2014; Vercammen et al., 1998) . MLKL, the mixed lineage kinase domain-like protein, has been identified as a key component downstream of RIPK3 (Sun et al., 2012; Zhao et al., 2012) . Recent studies have demonstrated that MLKL is phosphorylated by RIPK3 and form oligomers that translocate to cell membrane, leading to the disruption of membrane integrity (Cai et al., 2014; Chen et al., 2014; Dondelinger et al., 2014; Orozco et al., 2014; Su et al., 2014; Wang et al., 2014) .
The in vivo mechanism of RIPK1-RIPK3 necrosome-mediated necroptosis has been elucidated through intensive genetic studies. Targeted deletion of Fadd or Caspase-8 in mice causes embryonic lethality around embryonic day 11.5 (Varfolomeev et al., 1998; Yeh et al., 1998) , which is probably due to vascular, cardiac, and hematopoietic defects (Kang et al., 2004 (Kang et al., , 2008 Sakamaki et al., 2002) . The death of Fadd À/À or Casp8 À/À embryo can be rescued by co-deletion of Ripk1; however, similar to Ripk1 À/À mice, these mice die perinatally (Zhang et al., 2011; Rickard et al., 2014; Dillon et al., 2014; Kaiser et al., 2014; Kelliher et al., 1998) . Deletion of Ripk3 in Fadd À/À or Casp8 À/À mice also prevents the embryonic lethality (Dillon et al., 2012; Kaiser et al., 2011; Oberst et al., 2011) ; by contrast, Ripk3 À/À Fadd À/À and
Ripk3
À/À Casp8 À/À mice grow into fertile adults. Furthermore, co-deletion of Ripk3 and either Fadd or Caspase-8 can rescue Ripk1 À/À mice into adulthood (Rickard et al., 2014; Dillon et al., 2014; Kaiser et al., 2014; Dowling et al., 2015) . During necroptosis, the pseudokinase MLKL acts as a terminal executor downstream of necrosome formation. Thus, the strong evidence regarding the early embryonic death of 2011; Newton et al., 2014; Oberst et al., 2011) . Meanwhile, this disease also occurred in mice and humans containing mutations in FAS or FASL (Wilson et al., 2009) . It is notable that Caspase-8
Ripk1
À/À mice that are backcrossed to C57BL/6 mice background show milder lymphoproliferative disease compared to Caspase-8 À/À Ripk3 À/À mice (Rickard et al., 2014; Dillon et al., 2014; Dowling et al., 2015) , whereas the TKO mice generated without backcrossing display an opposite phenotype (Kaiser et al., 2014) . These results indicate that the extent of the backcross of knockout mice may have to do with the phenotypes. Interestingly, genetic loss of both FASL and TRAIL in mice displays more severe disease than in FASL mutant mice (Sedger et al., 2010) , which indicates that FAS may be one of the death receptors involving in progressive lymphoproliferative disease.
Together, the precise contributions of cell death pathways in the pathogenesis of lymphoproliferative disease remain unclear.
Another important process closely related to necrosis is inflammatory response. Damage-associated molecular patterns (DAMPs) released from necrotic cells stimulate immune cells through ligation of pattern recognition receptors (PRRs) to secret pro-inflammatory cytokines such as interleukin-1b (IL-1b) and IL-18, which subsequently activate host immune defenses against various pathogens. The maturation of IL-1b and IL-18 is mediated by cytosolic NOD-like receptors (NLRs) and HIN domaincontaining family member AIM2, which associate with other proteins to form large multimeric complex that is known as the inflammasome (Agostini et al., 2004; Davis et al., 2011; Schroder and Tschopp, 2010) . The NLRP3 inflammasome, the most extensively studied one, consists of NLRP3, the apoptosisassociated speck-like protein containing a CARD (ASC) and pro-caspase-1. Processed by the NLRP3 inflammasome, active caspase-1 subsequently promotes the maturation of the pro-inflammatory cytokines IL-1b and IL-18 (Fernandes-Alnemri et al., 2007; Latz et al., 2013; Schroder et al., 2012) .
In Caspase-8-deficient bone-marrow-derived dendritic cells (BMDCs), the NLRP3 inflammasome can be activated by lipopolysaccharide (LPS) treatment alone in a RIPK3-dependent manner, which is consistent with the results from cells deficient in XIAP, cIAP1, and cIAP2. Similarly, treatment of bonemarrow-derived macrophages (BMDMs) or BMDCs with Smac mimetics leads to the NLRP3 inflammasome activation, which requires RIPK3 (Kang et al., 2013; Silke et al., 2015; Vince et al., 2012 . Besides, keratinocyte-specific Fadd deficiency promoted RIPK3-dependent necroptosis and skin inflammation in mice (Bonnet et al., 2011) . Consistent with these results, Mlkl À/À Fadd À/À mice exhibited no sign of chronic inflammation in skin or intestine when observed for over 5 months (Figures 1B and S1C) , suggesting that RIPK3-MLKL-mediated necroptosis in epithelial cells is likely to participate in the pro-inflammatory signaling pathways when caspase-8 or FADD is inhibited. In conclusion, these results demonstrate that MLKL functionally mediates the consequences of Fadd deficiency in vivo.
Apoptosis and Necroptosis Cell death mostly initiates through the ligation of DRs and the signaling is relayed through a series of protein-protein hibitor Smac mimetic. In the presence of caspase inhibitor zVAD-fmk, almost half of the WT MDFs underwent necroptosis which was inhibited by Necrostatin-1 ( Figure 2A ). Thymocytes were killed by treatment with anti-Fas antibodies ( Figure 2B ). In addition, BMDMs from WT mice were sensitive to LPS or Poly(I:C)-induced necroptosis ( Figure 2C ). In contrast to WT cells, cells from Mlkl À/À Fadd À/À mice were completely resistant to the extrinsic apoptosis and necroptosis triggered by the stimuli described above (Figures 2A-2C ). Furthermore, Mlkl
Fadd À/À mice were resistant to Fas-induced lethal hepatitis and survived for over 24 hr ( Figure 2D ) with normal liver architecture ( Figure 2E) 
In all settings where Caspase-8 or Fadd deficiency has been rescued by elimination of Ripk3 or the kinase activity of RIPK3, resulting viable mice exhibit lymphoid hyperplasia as they age (Dillon et al., 2012; Kaiser et al., 2011; Newton et al., 2014; Oberst et al., 2011) . Similar to Ripk3 Figure 3C ). It seems that the remarkable distinction, comparing to Ripk3 À/À Fadd À/À mice, should owe to the praecox lymphoaccumulation (started around 9 weeks old, data not shown) and more rapid development of the disease in Mlkl
mice. Differences in organ sizes and B220 + CD3 + T lymphocytes percentage between two types of DKO mice became less significant over time ( Figures 3A, 3C , and S2A). Aging mice to about 16 weeks old, we found enlarged parathymic lymph nodes emerged beside the thymus (it appeared earlier in Mlkl
were confirmed to be accumulations of B220 + CD3 + T lymphocytes similar to those shown in spleen and other lymph nodes ( Figures 3A, S2A, and S2C) Figure S2D ). Thus, our data implicate that hyperproliferation of B220 + CD3 + T lymphocytes contributes to more severe
Inflammasome Activation When Challenged with LPS or Poly(I:C) Inflammasomes are large intracellular multiprotein complexes that play a central role in innate immunity. Recent studies have provided some evidence that FADD, RIPK3, and MLKL may be involved in regulating the NLRP3 inflammasome activation Kang et al., 2013 Kang et al., , 2015 Lawlor et al., 2015; Silke et al., 2015; Vince et al., 2012) . To investigate the function of these proteins in the NLRP3 inflammasome activation, we challenged Ripk3 Figure 4A ).
Consistently, IL-1b secretion was significantly decreased in Ripk3 Figure 4B ).
These BMDMs were also primed with poly(I:C) and treated with ATP for the inflammasome activation. Similar to the aforementioned results, Mlkl
to the treatment while the WT BMDMs had normal inflammasome activation ( Figures 4C and 4D) . Furthermore, the similar set of experiments was also performed in BMDCs. Mlkl À/À Fadd À/À BMDCs were defective in NLRP3 inflammasome activation as well ( Figures S4B and S4C ). Previous studies have revealed that FADD and caspase-8 were apical mediators of canonical and noncanonical NLRP3 inflammasome activation (Kang et al., 2013; Silke et al., 2015; Vince et al., 2012; Gurung et al., 2014) . To investigate the cause of the defect in DKO BMDMs, we examined the NLRP3 inflammasome activation in BMDMs derived from LysM-cre-mediated cell-specific Fadd deletion mice, and the deletion efficiency of FADD was tested by immunoblot ( Figure S4A ). The results showed that LPS or poly(I:C) primed BMDMs with low FADD expression had normal caspase-1 processing and IL-1b secretion upon stimulation as WT control ( Figures 4E and 4F ).
In conclusion, in contrast to the Ripk3 À/À , Mlkl À/À and FADD insufficient BMDMs, Ripk3
BMDMs or BMDCs have impaired canonical NLRP3 inflammasome activation when challenged with LPS or Poly(I:C). Our data suggest that MLKL is likely to function together with FADD to co-regulate the canonical NLRP3 inflammasome activation engaged through TLR3 or TLR4. (E) Wild-type and FADD insufficient BMDMs were primed with 20 ng/ml LPS or (C) 100 mg/ml Poly(I:C) for 5 hr prior to 30-min treatment of 5 mM ATP. Supernatants were analyzed by immunoblot for caspase-1 activation and (F) were analyzed by ELISA for IL-1b secretion. ***p < 0.001 (Student's t test). n.s., not significant. BMDMs treated with LPS, NLRP3 can hardly respond to the priming signal compared with WT control while ASC had normal transcription and expression levels in all BMDMs ( Figures 5A, 6A , and 6C). Besides, pro-IL1b, the substrate of the activated inflammasome, was unable to be upregu- immunoblots (Bauernfeind et al., 2009; Schroder et al., 2012; Sutterwala et al., 2014) . We found that NF-kB activation was significantly decreased associated with less phosphorylation and degradation of IkB in both Mlkl
Fadd À/À BMDMs than in WT BMDMs ( Figure 6D ). Furthermore, we examined the secretion levels of TNF-a and IL-6, which are the target genes of NF-kB. It was shown that Mlkl
BMDMs had notable reduction of TNF-a and IL-6 levels in comparison to WT controls ( Figures 6E and 6F ). In summary, our findings suggest that the NLRP3 inflammasome formation is insensitive to LPS/ATP stimulation in Mlkl
BMDMs. This is likely due to the defects in NF-kB-dependent Nlrp3 and pro-IL-1b transcriptions. Consequently, the lack of NLRP3 and pro-IL-1b expression renders the Mlkl
pable of forming ASC speck and recruiting other components to assemble the NLRP3 inflammasome complex, which results in the failure of caspase-1 processing and mature IL-1b secretion.
DISCUSSION
The findings of our study provide genetic evidence that MLKL mediates the embryonic lethality of Fadd deficiency in vivo. Combined with previous studies (Dillon et al., 2012; Kaiser et al., 2011; Oberst et al., 2011; Varfolomeev et al., 1998; Yeh et al., 1998) , we speculate that, during the embryonic development, RIPK3-MLKL-mediated necroptotic signaling is tightly regulated by the caspase-8-FADD-cFLIP complex although the function of MLKL in the condition of Caspase-8 genetic ablation remains to be identified. Several studies have intimated that Fadd or Caspase-8 deficiency induced RIPK3-dependent pathway may target the yolk sac vasculature and hematopoietic cells during embryogenesis. However, direct evidence showing that embryonic lethality of Fadd-deficient mice is caused by RIPK3-MLKL-mediating necroptosis must still be obtained.
Considering that the CRISPR/Cas9 system could introduce off-target effects in the Mlkl knockout mice, we confirmed the phenotypes using another Mlkl knockout mouse line that was generated by an independent single guide (sg)RNA ( Figures S3A and S3B ). The two independent lines of Mlkl knockout mice were individually crossed into the same line of Fadd-deficient mice, and the two lineages displayed equivalent properties, excluding the possibility that off-target effects contributed to the phenotypes of Mlkl Figure S3C ).
Previous studies have demonstrated that FASL-FAS signaling kills unwanted cells through FADD/caspase-8-mediated apoptosis during the development of lymphocytes. Conditional deletion of Fadd or Caspase-8 in T cell results in proliferation defects in response to activation signals (Zhang et al., 1998; Kabra et al., 2001; Salmena et al., 2003; Ch'en et al., 2008) Kang et al., 2013 Figures 4E and 4F) , it remains likely that FADD alone determines the NLRP3 inflammasome activation due to its incomplete deletion ( Figure S4A ). Thus, we hypothesized that RIPK3/MLKL and FADD/caspase-8 may co-regulate a target or targets that mediate NF-kB signaling upon LPS or Poly(I:C) stimulation. Nevertheless, the functions of these proteins in regulating the targets need to be clarified by sophisticated biochemical studies, and their functions in activating noncanonical NLRP3 inflammasome and other types of inflammasomes should be further investigated. The findings that FADD restricted MLKL-dependent pathway during embryonic development and in maintaining the homeostasis of T cell suggest the importance of the interplay between FADD-dependent apoptosis and MLKL-dependent necroptosis. More importantly, the key components of the two cell death pathways may function as regulators in other situations as we have observed in stimulating BMDMs or BMDCs. In this light, it is noteworthy that our findings here point out MLKL and FADD, which are multifunctional in regulating cell death and innate immune response, have broad implications for the related investigations as well as approaches to therapies of cancer and immune disorders.
EXPERIMENTAL PROCEDURES
Reagents LPS, ATP, and PolyI:C were obtained from Sigma. TNF-a and z-VAD were from R&D Systems and Calbiochem, respectively. Necrostatin-1 was purchased from Enzo Life Sciences. The following antibodies were used for western blotting and immunofluorescence experiments: RIPK1 (BD Biosciences), RIPK3 (Prosci), IkBa and p-IkBa (Cell Signaling Technology), ASC (Santa Cruz Biotechnology), IL-1b (Santa Cruz), mouse caspase-1 (AdipoGen), NLRP3 (R&D). MLKL antibody was a gift from Dr. Jiahuai Han (Xiamen University). FADD antibody was from Dr. Jianke Zhang (Thomas Jefferson University). Mouse TNF-a, IL-6, and IL-1b ELISA Kits were from MultiSciences. Cell viability was determined by measuring ATP levels using the Cell Titer-Glo kit (Promega).
Mice
Mice were housed in a specific pathogen-free (SPF) facility. Ripk3 knockout mice were provided by Dr. Xiaodong Wang (NIBS, Beijing, China), and Fadd À/À Tg mice were provided by Dr. Jianke Zhang (Thomas Jefferson University). Mlkl knockout mice were generated by CRISPR-Cas9 mutation system (Bioray Laboratories). A 301-bp deletion in the Mlkl gene was introduced in the Mlkl locus, and genotyping results of mice are presented in Figures S1A and S1B. Additional information is provided upon request. Animal experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee of the Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (CAS).
Cell Survival Assay
Cell survival was determined using the CellTiter-Glo Luminescent Cell Viability Assay kit, and the luminescence was recorded with a microplate luminometer (Thermo Scientific).
Isolation of Mouse BMDMs and Inflammasome Activation
Bone marrow cells were collected from mouse femurs and tibias and were cultured for 7 days in RPMI medium containing 10% fetal bovine serum (FBS), penicillin, streptomycin, and 50 ng/ml M-CSF. Medium was changed every 2 days. BMDMs were induced to differentiate in vitro from isolated bone marrow cells. For inflammasome assays, BMDMs were pretreated with LPS or Poly(I:C) for 5 hr before stimulated with ATP (5 mM) for 30 min. The media supernatant and cell lysates were collected for precipitation and immunoblot analysis.
ASC Oligomerization Detection ASC pyroptosomes were detected as previously reported (Juliana et al., 2010) . Macrophages were seeded in 6-well plates (2 3 10 6 cells per well) and treated with different stimuli. The cells were pelleted by centrifugation and resuspended in 0.5 ml of ice-cold buffer containing 20 mM HEPES-KOH (pH 7.5), 150 mM KCl, 1% Nonidet P-40, 0.1 mM PMSF, and a protease inhibitor mixture. Cell lysates were centrifuged at 5,000 3 g for 10 min at 4 C, and pellets were washed twice with PBS before being resuspended in 500 ml of PBS. The pellets were crosslinked with fresh DSS (4 mM) for 30 min and pelleted by centrifugation at 5,000 3 g for 10 min. Crosslinked pellets were resuspended in 30 ml of SDS sample buffer and subjected to western blot with the anti-mouse ASC antibodies.
Statistical Analysis
Data presented in this article are representative results of at least three independent experiments. The in vitro results were presented as the mean ± SD of triplicate wells. The statistical significance of data was evaluated by Student's t test in which p < 0.01 was considered significant and p < 0.001 was highly significant. The statistical calculations were performed with GraphPad Prism software. 
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